iShares Neuroscience and Healthcare ETF Rating $23.84 +0.28 (+1.19%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.87Holdings in IBRN have an aggregate rating of Moderate Buy based on 237 analyst ratings issued in the past year covering 18 companies (61.1% of the portfolio).IBRN Aggregate Price Target$23.84High Prediction$23.84Average Prediction$23.84Low Prediction$23.84Holdings in IBRN have an aggregate price target of $23.84 and a range of $23.84 to $23.84 covering 18 companies (61.1% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy7 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 18 IBRN Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.75%ARGXargenex$674.90-2.2%4.1201 of 5 stars3.10$746.81 10.7%21Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision4.41%ACADACADIA Pharmaceuticals$23.64-1.7%3.3958 of 5 stars2.71$28.13 19.0%17Upcoming Earnings4.39%SRRKScholar Rock$36.980.0%3.8398 of 5 stars3.22$44.14 19.4%9Positive NewsUpcoming Earnings4.35%SUPNSupernus Pharmaceuticals$37.53+1.3%1.8175 of 5 stars2.67$39.00 3.9%3News CoverageAnalyst Upgrade4.24%NBIXNeurocrine Biosciences$128.39+0.3%4.9022 of 5 stars2.86$160.90 25.3%22Trending NewsEarnings ReportAnalyst UpgradeAnalyst Revision4.14%PTCTPTC Therapeutics$51.11-2.2%4.4968 of 5 stars2.67$69.38 35.8%15Upcoming Earnings4.09%BIIBBiogen$132.89+0.5%4.8563 of 5 stars2.34$185.63 39.7%32Trending NewsEarnings ReportAnalyst UpgradeAnalyst Revision3.97%XENEXenon Pharmaceuticals$34.40+3.7%3.109 of 5 stars3.00$54.82 59.4%12News CoveragePositive NewsHigh Trading Volume3.77%DNLIDenali Therapeutics$14.29-1.0%4.5216 of 5 stars3.12$33.85 136.9%17Upcoming Earnings3.45%ALKSAlkermes$26.60-0.2%4.766 of 5 stars2.83$41.08 54.4%12Earnings ReportAnalyst Revision3.38%CPRXCatalyst Pharmaceuticals$22.22+2.3%4.8933 of 5 stars3.25$32.83 47.8%8News CoveragePositive NewsUpcoming Earnings3.03%BHVNBiohaven$15.22+3.4%2.3729 of 5 stars3.07$58.46 284.2%152.55%EWTXEdgewise Therapeutics$13.74+1.0%2.2543 of 5 stars2.91$40.55 195.1%11Positive NewsUpcoming Earnings2.28%PRAXPraxis Precision Medicines$47.79-6.5%1.8624 of 5 stars2.78$95.22 99.3%9Trending NewsEarnings ReportAnalyst ForecastGap Up2.26%AVDLAvadel Pharmaceuticals$11.15-1.0%2.6916 of 5 stars3.00$18.33 64.4%6Positive NewsUpcoming Earnings2.14%AVXLAnavex Life Sciences$10.89+0.6%3.6576 of 5 stars3.00$44.00 304.0%2News CoverageAnalyst Forecast1.98%DYNDyne Therapeutics$10.47+2.1%3.7641 of 5 stars3.00$36.25 246.2%17News CoverageUpcoming Earnings1.87%IARTIntegra LifeSciences$12.73+1.4%4.2579 of 5 stars1.78$18.63 46.3%9Earnings ReportGap Down This page (NYSEARCA:IBRN) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBRN Stock Alerts